Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

JCRRF

JCR Pharmaceuticals Co., Ltd.

USD

Set alert

Price alert · JCRRF

All alert types
3.73 USD 0.00 0.00%
As of Oct 29, 2026
3.60 Day range 3.60
3.15 52-week range 4.75
YTD
-21.47%
1 year
-17.11%
Open
3.60
Prev close
3.73
Mkt cap
455.12M
Vol
100
Avg vol
14
EPS
-0.18
P/E
0.00
More statistics
Low
3.60
High
3.60

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for JCRRF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.12 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 37.6×
FY 2017: 256×FY 2018: 146×FY 2019: 125×FY 2020: 168×FY 2021: 67.1×FY 2022: 18.6×FY 2023: 45.5×FY 2024: 31.1×FY 2025: -17.8×FY 2026: 37.6×
FY 2017 5y median 31.1× FY 2026
P/S 2.0×
FY 2017: 26.4×FY 2018: 21.7×FY 2019: 20.0×FY 2020: 18.1×FY 2021: 15.4×FY 2022: 5.3×FY 2023: 5.0×FY 2024: 4.0×FY 2025: 2.6×FY 2026: 2.0×
FY 2017 5y median 4.0× FY 2026
P/B 1.7×
FY 2017: 17.3×FY 2018: 16.4×FY 2019: 15.1×FY 2020: 13.9×FY 2021: 12.1×FY 2022: 5.3×FY 2023: 3.3×FY 2024: 3.0×FY 2025: 1.8×FY 2026: 1.7×
FY 2017 5y median 3.0× FY 2026
P/FCF -6.9×
FY 2017: 433×FY 2018: 210×FY 2019: 154×FY 2020: 5040×FY 2021: 164×FY 2022: -132×FY 2023: -12.2×FY 2024: 23.7×FY 2025: -5.5×FY 2026: -6.9×
FY 2017 5y median -6.9× FY 2026
EV/EBITDA 40.2×
FY 2017: 120×FY 2018: 86.8×FY 2019: 73.2×FY 2020: 95.4×FY 2021: 42.9×FY 2022: 12.0×FY 2023: 24.3×FY 2024: 16.7×FY 2025: -38.0×FY 2026: 40.2×
FY 2017 5y median 16.7× FY 2026
EV/Sales 3.0×
FY 2017: 26.3×FY 2018: 21.8×FY 2019: 19.9×FY 2020: 18.0×FY 2021: 15.1×FY 2022: 5.0×FY 2023: 5.3×FY 2024: 4.1×FY 2025: 3.3×FY 2026: 3.0×
FY 2017 5y median 4.1× FY 2026
FCF Yield -14.4%
FY 2017: 0.2%FY 2018: 0.5%FY 2019: 0.6%FY 2020: 0.0%FY 2021: 0.6%FY 2022: -0.8%FY 2023: -8.2%FY 2024: 4.2%FY 2025: -18.1%FY 2026: -14.4%
FY 2017 5y median -8.2% FY 2026

Profitability

Gross Margin 74.6%
FY 2017: 68.3%FY 2018: 70.2%FY 2019: 71.6%FY 2020: 68.1%FY 2021: 74.0%FY 2022: 79.5%FY 2023: 74.1%FY 2024: 72.9%FY 2025: 65.7%FY 2026: 74.6%
FY 2017 5y median 74.1% FY 2026
Operating Margin 1.1%
FY 2017: 13.1%FY 2018: 18.4%FY 2019: 21.4%FY 2020: 13.1%FY 2021: 27.5%FY 2022: 39.0%FY 2023: 14.5%FY 2024: 17.6%FY 2025: -20.1%FY 2026: 1.1%
FY 2017 5y median 14.5% FY 2026
Net Margin 5.4%
FY 2017: 10.3%FY 2018: 14.9%FY 2019: 16.0%FY 2020: 10.8%FY 2021: 22.9%FY 2022: 28.4%FY 2023: 11.0%FY 2024: 12.8%FY 2025: -14.4%FY 2026: 5.4%
FY 2017 5y median 11.0% FY 2026
ROE 4.6%
FY 2017: 6.8%FY 2018: 11.2%FY 2019: 12.1%FY 2020: 8.3%FY 2021: 18.0%FY 2022: 28.5%FY 2023: 7.2%FY 2024: 9.8%FY 2025: -10.1%FY 2026: 4.6%
FY 2017 5y median 7.2% FY 2026
ROIC 0.3%
FY 2017: 5.3%FY 2018: 8.7%FY 2019: 9.9%FY 2020: 6.0%FY 2021: 11.4%FY 2022: 21.2%FY 2023: 4.6%FY 2024: 7.1%FY 2025: -5.6%FY 2026: 0.3%
FY 2017 5y median 4.6% FY 2026
ROA 2.0%
FY 2017: 5.1%FY 2018: 8.0%FY 2019: 8.7%FY 2020: 5.6%FY 2021: 9.3%FY 2022: 14.9%FY 2023: 4.0%FY 2024: 5.4%FY 2025: -4.5%FY 2026: 2.0%
FY 2017 5y median 4.0% FY 2026

Growth (YoY)

Revenue 22.7%
FY 2017: 3.7%FY 2018: 13.9%FY 2019: 12.5%FY 2020: 7.0%FY 2021: 21.4%FY 2022: 69.8%FY 2023: -32.8%FY 2024: 24.8%FY 2025: -22.9%FY 2026: 22.7%
FY 2017 FY 2026
Operating Income 106.5%
FY 2017: 9.7%FY 2018: 60.2%FY 2019: 31.3%FY 2020: -34.7%FY 2021: 154.9%FY 2022: 141.1%FY 2023: -75.0%FY 2024: 51.4%FY 2025: -188.3%FY 2026: 106.5%
FY 2017 FY 2026
EPS (diluted) 145.7%
FY 2017: 5.0%FY 2018: 67.4%FY 2019: 22.3%FY 2020: -28.0%FY 2021: 157.2%FY 2022: 110.4%FY 2023: -74.1%FY 2024: 45.3%FY 2025: -187.5%FY 2026: 145.7%
FY 2017 FY 2026
Free Cash Flow 24.3%
FY 2017: 39.7%FY 2018: 93.9%FY 2019: 41.0%FY 2020: -97.0%FY 2021: 3061.8%FY 2022: -172.6%FY 2023: -587.9%FY 2024: 151.3%FY 2025: -313.0%FY 2026: 24.3%
FY 2017 FY 2026

Financial Health

Current Ratio 1.2×
FY 2017: 4.3×FY 2018: 3.3×FY 2019: 3.2×FY 2020: 2.7×FY 2021: 1.7×FY 2022: 1.5×FY 2023: 1.3×FY 2024: 1.9×FY 2025: 1.2×FY 2026: 1.2×
FY 2017 5y median 1.3× FY 2026
Quick Ratio 0.7×
FY 2017: 2.7×FY 2018: 2.0×FY 2019: 2.1×FY 2020: 1.9×FY 2021: 1.2×FY 2022: 1.1×FY 2023: 0.8×FY 2024: 1.2×FY 2025: 0.7×FY 2026: 0.7×
FY 2017 5y median 0.8× FY 2026
Debt / Equity 1.1×
FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.3×FY 2021: 0.5×FY 2022: 0.4×FY 2023: 0.4×FY 2024: 0.4×FY 2025: 0.8×FY 2026: 1.1×
FY 2017 5y median 0.4× FY 2026
Net Debt / EBITDA 13.3×
FY 2017: -0.2×FY 2018: 0.2×FY 2019: -0.3×FY 2020: -0.5×FY 2021: -0.8×FY 2022: -0.6×FY 2023: 1.3×FY 2024: 0.4×FY 2025: -8.6×FY 2026: 13.3×
FY 2017 5y median 0.4× FY 2026
Interest Coverage 1.1×
FY 2017: 81.5×FY 2018: 140×FY 2019: 237×FY 2020: 147×FY 2021: 197×FY 2022: 443×FY 2023: 113×FY 2024: 87.6×FY 2025: -42.9×FY 2026: 1.1×
FY 2017 5y median 87.6× FY 2026

Dividends

Dividend Yield 3.0%
FY 2017: 0.1%FY 2018: 0.2%FY 2019: 0.2%FY 2020: 0.2%FY 2021: 0.2%FY 2022: 0.8%FY 2023: 1.6%FY 2024: 1.5%FY 2025: 3.0%FY 2026: 3.0%
FY 2017 5y median 1.6% FY 2026
Payout Ratio 112.0%
FY 2017: 37.5%FY 2018: 24.4%FY 2019: 22.4%FY 2020: 36.9%FY 2021: 15.7%FY 2022: 15.0%FY 2023: 72.6%FY 2024: 45.4%FY 2025: -52.6%FY 2026: 112.0%
FY 2017 5y median 45.4% FY 2026

Annual · latest fiscal year ends 2026-03-31